HIF1A and central nervous system cancer: Interestingly, it has also been shown that targeting mitochondrial function and OXPHOS can destabilize hypoxia-inducible factor 1-alpha (HIF-1α), a critical regulator of glioma progression under hypoxic conditions [109].